Mechanisms of neurotoxicity of amyloid aggregates

Lead Research Organisation: University of Cambridge
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

Some of the most important but unresolved questions about the pathobiology of Alzheimers disease (AD) are: What are the neurotoxic species of Abeta? How do they injure neurons? How do they induce aggregation of intracellular proteins like tau, ?-synuclein, and TDP-43? Why are the normal mechanisms for removal of these intracellular aggregation-prone proteins overwhelmed in AD? Answers to such questions will provide both insight into the early stages of disease pathogenesis, and starting points for the discovery of novel diagnostics and therapeutics.|We hypothesize that the neurotoxicity of Abeta arises from heterogeneous mixtures of|soluble Abeta aggregates, which may have differing toxicities, but which activate complex, interlinked downstream pathways. To deconvolute this complexity we will apply an integrated suite of tools from physics, chemistry, engineering, systems biology and neurobiology to: 1) Investigate Abeta aggregation and its consequences in living cells and animals; 2) Identify its molecular targets; 3) Discover the downstream metabolic and signalling pathways activated by Abeta; 4) Identify the molecular mechanisms by which Abeta induces misprocessing of tau; and 5) Identify the regulators of autophagy (which is an important physiological mechanisms for removal of tau)|and determine why autophagy is down-regulated in AD).||

Publications

10 25 50
 
Description Dementia Advisory Panel, Biomarkers for Dementia, Cabinet Office for Life Sciences
Geographic Reach National 
Policy Influence Type Participation in a guidance/advisory committee
Impact Advised government of work on biomarkers for dementia with implications for public health and for pharmaceutical industry
 
Description Future Health Forum
Geographic Reach Multiple continents/international 
Policy Influence Type Implementation circular/rapid advice/letter to e.g. Ministry of Health
Impact Health care and social impact policy. UK-Korea governments forum
 
Description G8 Summit - Showcasing British Successes in Dementia Research
Geographic Reach Multiple continents/international 
Policy Influence Type Implementation circular/rapid advice/letter to e.g. Ministry of Health
Impact Showcase event described British work on dementia biomarkers, therapeutic targets, cohorts assembled by the the Dept of Health (NOCRI, NIHR) and Medical Rsearch Council.. to encourage dementia-related business investment in UK
 
Description MRC-KHIDI signed MOU
Geographic Reach Multiple continents/international 
Policy Influence Type Implementation circular/rapid advice/letter to e.g. Ministry of Health
 
Description Ministerial Advisory Group on Dementia Research
Geographic Reach National 
Policy Influence Type Participation in a guidance/advisory committee
Impact Improved government understanding of the research needs in Alzheimer's disease setting of G8 Dementia work
 
Description Prime Minister David Cameron's Dementia Research Champion Group
Geographic Reach National 
Policy Influence Type Participation in a guidance/advisory committee
Impact Provided input to MRC and government officials concerning the potential interactions between academic and industrial sites in the area of Alzheimer's disease therapies.
 
Description Research and Health Care Policy Advice
Geographic Reach Europe 
Policy Influence Type Implementation circular/rapid advice/letter to e.g. Ministry of Health
Impact Establish research oriented hospital scheme in Korea and build UK-Korea research and health care policy forum for Dementia.
 
Description Alzheimer's Research UK
Amount £30,000 (GBP)
Organisation Alzheimer's Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2012 
End 12/2017
 
Description Alzheimer's Research UK
Amount £20,000 (GBP)
Organisation Alzheimer's Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2012 
 
Description Alzheimer's Research UK equipment grant
Amount £100,000 (GBP)
Organisation Alzheimer's Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2012 
 
Description Bilateral Programme
Amount £14,000 (GBP)
Organisation Foreign Commonwealth and Development Office (FCDO) 
Sector Public
Country United Kingdom
Start 04/2016 
End 03/2017
 
Description CIHR / China-Canada: Alzheimer's disease
Amount £630,283 (GBP)
Organisation Canadian Institutes of Health Research 
Sector Public
Country Canada
Start 01/2011 
End 01/2015
 
Description CIHR / China-Canada: Alzheimer's disease
Amount £630,283 (GBP)
Organisation Canadian Institutes of Health Research 
Sector Public
Country Canada
Start 01/2012 
End 01/2016
 
Description CIHR / China-Canada: Alzheimer's disease
Amount $1,000,000 (CAD)
Organisation Canadian Institutes of Health Research 
Sector Public
Country Canada
Start 01/2013 
End 12/2018
 
Description CIHR Operating Grant
Amount £942,283 (GBP)
Organisation Canadian Institutes of Health Research 
Sector Public
Country Canada
Start 01/2011 
End 01/2016
 
Description CIHR Salary Support
Amount £85,000 (GBP)
Organisation Canadian Institutes of Health Research 
Sector Public
Country Canada
Start 01/2012 
End 01/2015
 
Description CIHR operating grant
Amount £1,153,590 (GBP)
Organisation Canadian Institutes of Health Research 
Sector Public
Country Canada
Start 01/2011 
End 01/2016
 
Description Canadian Institutes of Health Research (CIHR)
Amount £619,000 (GBP)
Organisation Canadian Institutes of Health Research 
Sector Public
Country Canada
Start 01/2012 
 
Description Canadian Institutes of Health Research (CIHR)
Amount £435,900 (GBP)
Organisation Canadian Institutes of Health Research 
Sector Public
Country Canada
Start 01/2012 
 
Description Collaborative Research Grant
Amount £2,200,000 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 03/2017 
End 02/2021
 
Description Elan Pharmaceuticals PhD studentship
Amount £90,000 (GBP)
Organisation Perrigo 
Department Elan Pharmaceuticals
Sector Private
Country Ireland
Start 01/2012 
 
Description Engineering and Physical Sciences Research Council (EPSRC) and National Physical Laboratory (NPL)
Amount £302,000 (GBP)
Organisation Engineering and Physical Sciences Research Council (EPSRC) 
Sector Public
Country United Kingdom
Start 01/2010 
End 01/2013
 
Description Frances and Augustus Newman Foundation
Amount £50,000 (GBP)
Organisation The Frances and Augustus Newman Foundation 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2012 
 
Description Fund for Translational Neuroscience
Amount £300,000 (GBP)
Organisation Chonnam National University Hospital (CNUH) 
Sector Hospitals
Country Korea, Republic of
Start 01/2012 
 
Description Medical Research Council (MRC)
Amount £1 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 01/2012 
End 01/2013
 
Description National Institutes for Health (NIH)
Amount £1,286,800 (GBP)
Organisation National Institutes of Health (NIH) 
Sector Public
Country United States
Start 01/2012 
 
Description National Institutes of Health Biomedical Research in Dementia
Amount £4,500,000 (GBP)
Organisation National Institute for Health Research 
Department NIHR Cambridge Biomedical Research Centre
Sector Academic/University
Country United Kingdom
Start 01/2012 
End 12/2017
 
Description Network of Centres of Excellence in Neurodegeneration (COEN)
Amount £100,000 (GBP)
Organisation Network of Centres of Excellence in Neurodegeneration (COEN) 
Sector Public
Country United Kingdom
Start 01/2012 
 
Description PrioNET
Amount £311,343 (GBP)
Organisation PrioNet 
Sector Charity/Non Profit
Country Canada
Start 01/2011 
End 01/2013
 
Description SUMOylation and Amyloid-Beta Elevation
Amount $2,042,362 (USD)
Organisation National Institutes of Health (NIH) 
Sector Public
Country United States
Start 01/2012 
End 12/2017
 
Description UK Dementia Research Institute Professorship
Amount £1,500,000 (GBP)
Organisation UK Dementia Research Institute 
Sector Charity/Non Profit
Country United Kingdom
Start 03/2018 
End 12/2023
 
Description UK-Korea Neuroscience Symposium
Amount £20,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 08/2016 
End 07/2017
 
Description UK-Korea Partnering Award
Amount £9,800 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 05/2016 
End 04/2017
 
Title esyN ( Easy Networks) 
Description esyN - online tool designed to make building, sharing and publishing biological networks as easy as possible. Users can build networks using the templates provided and the pathways published previously. esyN is free to use and no registration is required - projects can be saved offline. Registered users can save projects online, share projects with collaborators and publish projects - all for free. 
Type Of Material Database/Collection of data 
Year Produced 2014 
Provided To Others? Yes  
Impact This database was launched March 2014 but the relevant paper describing it was published only in Sept 2014. Despite being very young, esyN is starting to become populated with all sorts of biological networks, especially with ones describing processes in Alzheimer's Disease and other neurodegenerative disorders. 
URL http://www.esyn.org/index.php
 
Description BSI-RIKEN 
Organisation RIKEN
Department RIKEN Brain Science Institute
Country Japan 
Sector Public 
PI Contribution Collaboration with Dr Yasunori Hayashi
Collaborator Contribution Collaboration with Dr Yasunori Hayashi
Impact Collaboration with Dr Yasunori Hayashi
Start Year 2012
 
Description Bristol-BSI RIKEN 
Organisation RIKEN
Department RIKEN Brain Science Institute
Country Japan 
Sector Public 
PI Contribution Electrophysiological and molecular assays in vitro.
Collaborator Contribution Tau protein constructs and vivo electrophysiology
Impact Kimura K., Whitcomb D.J., Jo J., Regan R., Piers T., Heo S., Brown C., Hashikawa T., Murayama M., Seok H., Sotiropoulos I., Kim E., Collingridge G.L., Takashima A. and Cho K. (2013) Microtubule associated protein tau (MAPT) is essential for long-term depression in the hippocampus. Phil. Trans. R. Soc. B 369, 2013144.
Start Year 2012
 
Description Bristol-Chonnam Univ Hospital 
Organisation Chonnam National University Hospital (CNUH)
Country Korea, Republic of 
Sector Hospitals 
PI Contribution Set research lab in Chonnam Nat Univ Hospital.
Collaborator Contribution Molecular biology
Impact Whitehead G., Jo J., Hogg E.L., Piers T.M., Kim D.H., Seaton G., Seok H., Bru-Mercier G., Son G.H., Regan P., Hildebrandt L., Waite E., Kim B.C., Kerrigan T.L., Kim K., Whitcomb D.J., Collingridge G.L., Lightman S.L., Cho K. (2013). Acute stress causes rapid synaptic insertion of Ca2+-permeable AMPA receptors to facilitate long-term potentiation in the hippocampus. Brain 136, 3753-3765. Kimura K., Whitcomb D.J., Jo J., Regan R., Piers T., Heo S., Brown C., Hashikawa T., Murayama M., Seok H., Sotiropoulos I., Kim E., Collingridge G.L., Takashima A. and Cho K. (2013) Microtubule associated protein tau (MAPT) is essential for long-term depression in the hippocampus. Phil. Trans. R. Soc. B 369, 2013144.
Start Year 2013
 
Description Bristol-IBS collaboration 
Organisation Korea Advanced Institute of Science and Technology (KAIST)
Country Korea, Republic of 
Sector Academic/University 
PI Contribution N/A
Collaborator Contribution AMPA receptor shRNA constrcuts and point mutations.
Impact Whitehead G., Jo J., Hogg E.L., Piers T.M., Kim D.H., Seaton G., Seok H., Bru-Mercier G., Son G.H., Regan P., Hildebrandt L., Waite E., Kim B.C., Kerrigan T.L., Kim K., Whitcomb D.J., Collingridge G.L., Lightman S.L., Cho K. (2013). Acute stress causes rapid synaptic insertion of Ca2+-permeable AMPA receptors to facilitate long-term potentiation in the hippocampus. Brain 136, 3753-3765. Kimura K., Whitcomb D.J., Jo J., Regan R., Piers T., Heo S., Brown C., Hashikawa T., Murayama M., Seok H., Sotiropoulos I., Kim E., Collingridge G.L., Takashima A. and Cho K. (2013) Microtubule associated protein tau (MAPT) is essential for long-term depression in the hippocampus. Phil. Trans. R. Soc. B 369, 2013144.
Start Year 2013
 
Description Cambridge Institute for Medical Research, University of Cambridge 
Organisation University of Cambridge
Department Cambridge Institute for Medical Research (CIMR)
Country United Kingdom 
Sector Academic/University 
PI Contribution Partnership with: Prof David Ron (UCAM): In vivo fluorescent lifetime imaging of a redox-sensitive green fluorescent protein tracks disulfide bond formation in the endoplasmic reticulum. Our contribution: TCSPC imaging of redox sensors Partner contribution: Sensor Design.
Collaborator Contribution Partnership with: Prof David Ron (UCAM): In vivo fluorescent lifetime imaging of a redox-sensitive green fluorescent protein tracks disulfide bond formation in the endoplasmic reticulum. Our contribution: TCSPC imaging of redox sensors Partner contribution: Sensor Design.
Impact Partnership with: Prof David Ron (UCAM): In vivo fluorescent lifetime imaging of a redox-sensitive green fluorescent protein tracks disulfide bond formation in the endoplasmic reticulum. Our contribution: TCSPC imaging of redox sensors Partner contribution: Sensor Design.
Start Year 2012
 
Description Cambridge Institute for Medical Research, University of Cambridge 
Organisation University of Cambridge
Department Cambridge Institute for Medical Research (CIMR)
Country United Kingdom 
Sector Academic/University 
PI Contribution Collaboration with James Fawcett/Maria Spillantini looking at manipulations of extracellular matrix to increase plasticity and ameliorate cognitive symptoms in mouse models of AD
Collaborator Contribution Collaboration with James Fawcett/Maria Spillantini looking at manipulations of extracellular matrix to increase plasticity and ameliorate cognitive symptoms in mouse models of AD
Impact Collaboration with James Fawcett/Maria Spillantini looking at manipulations of extracellular matrix to increase plasticity and ameliorate cognitive symptoms in mouse models of AD
Start Year 2012
 
Description Cambridge Institute for Medical Research, University of Cambridge 
Organisation University of Cambridge
Department Cambridge Institute for Medical Research (CIMR)
Country United Kingdom 
Sector Academic/University 
PI Contribution Collaboration with: Prof. Peter St George-Hyslop (UCAM): Imaging of protein aggregation in C. elegans. We performed fluorescence lifetime imaging microscopy to monitor FUS aggregation in C.Elegans and effects and to test a toxic gain of function hypothesis of FUS aggregation. Collaborator provided Reagents, Samples and defined biological Model system
Collaborator Contribution Collaboration with: Prof. Peter St George-Hyslop (UCAM): Imaging of protein aggregation in C. elegans. We performed fluorescence lifetime imaging microscopy to monitor FUS aggregation in C.Elegans and effects and to test a toxic gain of function hypothesis of FUS aggregation. Collaborator provided Reagents, Samples and defined biological Model system
Impact Collaboration with: Prof. Peter St George-Hyslop (UCAM): Imaging of protein aggregation in C. elegans. We performed fluorescence lifetime imaging microscopy to monitor FUS aggregation in C.Elegans and effects and to test a toxic gain of function hypothesis of FUS aggregation. Collaborator provided Reagents, Samples and defined biological Model system
Start Year 2012
 
Description Cambridge Institute for Medical Research, University of Cambridge 
Organisation University of Cambridge
Department Cambridge Institute for Medical Research (CIMR)
Country United Kingdom 
Sector Academic/University 
PI Contribution Collaboration with Prof. Alan Tunnacliffe (UCAM): Intrinsically Disordered Proteins As molecular shields We applied the techniques developed to study amyloidogenesis in vivo to a new problem of a similar nature: chaperone activity of intrinsically disordered proteins to prevent aggregation. Collaborator provided reagents, infrastructure, and people
Collaborator Contribution Collaboration with Prof. Alan Tunnacliffe (UCAM): Intrinsically Disordered Proteins As molecular shields We applied the techniques developed to study amyloidogenesis in vivo to a new problem of a similar nature: chaperone activity of intrinsically disordered proteins to prevent aggregation. Collaborator provided reagents, infrastructure, and people
Impact Collaboration with Prof. Alan Tunnacliffe (UCAM): Intrinsically Disordered Proteins As molecular shields We applied the techniques developed to study amyloidogenesis in vivo to a new problem of a similar nature: chaperone activity of intrinsically disordered proteins to prevent aggregation. Collaborator provided reagents, infrastructure, and people
Start Year 2012
 
Description Cambridge Institute for Medical Research, University of Cambridge 
Organisation University of Cambridge
Department Cambridge Institute for Medical Research (CIMR)
Country United Kingdom 
Sector Academic/University 
PI Contribution Collaboration with: Dr. Florian Hollfelder, UCAM: Droplet Cages as a Platform for Monitoring Amyloid Aggregation. We combined our FRET aggregation assay with their droplet cages to develop a new platform to study amyloid aggregation. Collaborators developed droplet cage assay
Collaborator Contribution Collaboration with: Dr. Florian Hollfelder, UCAM: Droplet Cages as a Platform for Monitoring Amyloid Aggregation. We combined our FRET aggregation assay with their droplet cages to develop a new platform to study amyloid aggregation. Collaborators developed droplet cage assay
Impact Collaboration with: Dr. Florian Hollfelder, UCAM: Droplet Cages as a Platform for Monitoring Amyloid Aggregation. We combined our FRET aggregation assay with their droplet cages to develop a new platform to study amyloid aggregation. Collaborators developed droplet cage assay
Start Year 2012
 
Description Cambridge Institute for Medical Research, University of Cambridge 
Organisation University of Cambridge
Department Cambridge Institute for Medical Research (CIMR)
Country United Kingdom 
Sector Academic/University 
PI Contribution Collaboration with: Prof. Christopher Dobson: Analysis of the Native Structure, Stability and Aggregation of Biotinylated Human Lysozyme. We have performed superresolution imaging of human lysozyme fibrils in situ. Collaborators produced labelled human lysozyme fibrils for analysis
Collaborator Contribution Collaboration with: Prof. Christopher Dobson: Analysis of the Native Structure, Stability and Aggregation of Biotinylated Human Lysozyme. We have performed superresolution imaging of human lysozyme fibrils in situ. Collaborators produced labelled human lysozyme fibrils for analysis
Impact Collaboration with: Prof. Christopher Dobson: Analysis of the Native Structure, Stability and Aggregation of Biotinylated Human Lysozyme. We have performed superresolution imaging of human lysozyme fibrils in situ. Collaborators produced labelled human lysozyme fibrils for analysis
Start Year 2012
 
Description Collaboration with commercial partner 
Organisation Perrigo
Department Elan Pharmaceuticals
Country Ireland 
Sector Private 
PI Contribution Elan Pharmaceuticals
Collaborator Contribution Establishment of Cambridge-Elan Centre for Research Innovation and Drug Discovery with Elan Pharmaceuticals Inc." See http://www.cam.ac.uk/research/news/cambridge-elan-centre-for-research-innovation-and-drug-discovery-launched/ for details
Impact Establishment of Cambridge-Elan Centre for Research Innovation and Drug Discovery with Elan Pharmaceuticals Inc." See http://www.cam.ac.uk/research/news/cambridge-elan-centre-for-research-innovation-and-drug-discovery-launched/ for details
Start Year 2012
 
Description Collaboration with commercial partners - Elan Pharmaceuticals 
Organisation Perrigo
Department Elan Pharmaceuticals
Country Ireland 
Sector Private 
PI Contribution Small molecule inhibition of protein aggregation Use of Lifetime imaging to test anti aggregation compounds in live cell models of Alzheimer's disease.
Collaborator Contribution Small molecule inhibition of protein aggregation Use of Lifetime imaging to test anti aggregation compounds in live cell models of Alzheimer's disease.
Impact Small molecule inhibition of protein aggregation Use of Lifetime imaging to test anti aggregation compounds in live cell models of Alzheimer's disease.
Start Year 2012
 
Description Combining light-sheet microscopy and magnetic tweezing to probe tissue mechanics in developing Embryos (Craig Russell/Richard Adams) 
Organisation University of Cambridge
Department Virology
Country United Kingdom 
Sector Academic/University 
PI Contribution Live, multicolour 3D imaging of Zebrafish developing and data analysis
Collaborator Contribution Biological question, provided zebrafish, bnuilt magnetic tweezer system
Impact Collaboration ongoing/paper in prep Multidisciplinary: Physics, chemistry, developmental biology
Start Year 2014
 
Description De novo design of a biologically active amyloid (Frederic Rousseau and Joost Schymkowitz) 
Organisation University of Leuven
Department Laboratory of Angiogenesis and Vascular Metabolism
Country Belgium 
Sector Academic/University 
PI Contribution Verification of protein colocalisation betwen designer amyloid and native protein via two colour dSTORM imaging. Analysis of colocalisation data
Collaborator Contribution Synthetic amyloid design, provision of biological questions, modelling of protein misfolding and aggregation behaviour.
Impact Publication: DOI:10.1126/science.aah4949 Multidisciplinary: Physics, structural biology
Start Year 2015
 
Description Drug discovery for Alzheimer's disease, The Korea Brain Research Institute 
Organisation Korea Brain Research Institute
Country Korea, Republic of 
Sector Public 
PI Contribution 1. Supervise full time PhD student. 2. Provide neurophysiology and tau-pathophysiology knowledge
Collaborator Contribution Vivo assays from transgenic animal model of Alzheimer's disease.
Impact We established bilateral candidate search (eg, Bio-informatics and muti-omic approach)
Start Year 2020
 
Description Graham George, Jake Pushie and Stanley Prusiner 
Organisation University of Cambridge
Department Cambridge Institute for Medical Research (CIMR)
Country United Kingdom 
Sector Academic/University 
PI Contribution Collaboration with Graham George, Jake Pushie and Stanley Prusiner to study in vivo affects of neurodegeneration on metal homeostasis using X-Ray Fluorescence (XRF) technology
Collaborator Contribution Collaboration with Graham George, Jake Pushie and Stanley Prusiner to study in vivo affects of neurodegeneration on metal homeostasis using X-Ray Fluorescence (XRF) technology
Impact Collaboration with Graham George, Jake Pushie and Stanley Prusiner to study in vivo affects of neurodegeneration on metal homeostasis using X-Ray Fluorescence (XRF) technology
Start Year 2012
 
Description Korea Alzheimer's disease research consortium 
Organisation Seoul National University
Country Korea, Republic of 
Sector Academic/University 
PI Contribution UK-Korea collaboration in Neurodegeneration under the Korean Ministry of Health and Welfare.
Collaborator Contribution Research tool (miRNA)
Impact Lee M., Kim K., Kwon J. H., An O. B., Ryu K., Cho, K., Suh, Y. H. and Kim, H. S. (2012) An activity-regulated microRNA, miR-188, controls dendritic plasticity and synaptic transmission by downregulating neuropilin-2. J of Neurosci 32, 5678-5687.
Start Year 2012
 
Description Liquid droplets and phase transitions in disease (Peter St G. Hyslop) 
Organisation University of Cambridge
Department Department of Biochemistry
Country United Kingdom 
Sector Academic/University 
PI Contribution Performed single particle tracking in wild type and mutant hydrogels formed of FUS protein. Performed high resolution experiments in axonal growth cones of FUS distribution and phase states. Used optical technique to look at FUS phase states in live cells.
Collaborator Contribution Hyslop set up protein expression system, defined experiments in biological models, supplied biological materials and helped in analysis of data.
Impact Successful follow on grant with WT/MRC Multidisciplinary: neuroscience, biophysics
Start Year 2012
 
Description Multicenter international study 
Organisation International Collaborative Effort for DMD
Country Global 
Sector Academic/University 
PI Contribution Participation in new multicenter international clinical/genetic study to assess the role of GBA mutations in Lewy Body Dementia (DLB). We demonstrated that GBA plays a large role in the genetic etiology of DLB (OR=8) (in press)
Collaborator Contribution Participation in new multicenter international clinical/genetic study to assess the role of GBA mutations in Lewy Body Dementia (DLB). We demonstrated that GBA plays a large role in the genetic etiology of DLB (OR=8) (in press)
Impact Participation in new multicenter international clinical/genetic study to assess the role of GBA mutations in Lewy Body Dementia (DLB). We demonstrated that GBA plays a large role in the genetic etiology of DLB (OR=8) (in press)
Start Year 2012
 
Description Ontario Research Fund collaboration with University of Toronto 
Organisation University of Toronto
Department Tanz Centre for Research in Neurodegenerative Diseases
Country Canada 
Sector Academic/University 
PI Contribution Biophysics from Cambridge, Genetics from Toronto
Collaborator Contribution Reagents and concepts
Impact Multidisciplinary work oin genetics and biophysics. Has led to understanding of role of clusterin in Alzheimers disease and papers published in Nature Genetics and in press in Nature Molecular and Structural Biology
Start Year 2011
 
Description Prof. Sir David Klenerman 
Organisation University of Cambridge
Country United Kingdom 
Sector Academic/University 
PI Contribution Neurophysiology (long-term synaptic plasticity) assay in hippocampus.
Collaborator Contribution Chemical assay for microglia-mediated neurodegeneration.
Impact Joint publication: 1. Hughes C., Choi M.L., Yi J-H, Kim S-C, Drews A., St.George-Hyslop P., Bryant C., Gandhi S., Cho K. and Klenerman D. (2020) Aß aggregates induce sensitised TLR4 signalling causing LTP deficit and neuronal cell death. Nature Commun Biol.3:79
Start Year 2019
 
Description Protein aggregation and neurotoxicity 
Organisation University of Cambridge
Department Department of Chemistry
Country United Kingdom 
Sector Academic/University 
PI Contribution Using different research tools, this collaboration bring together between neurophysiology and molecular imaging in living tissue
Collaborator Contribution Advanced molecular imaging tool with nano-scale resolution.
Impact We are preparing research manuscript to submit.
Start Year 2017
 
Description Research groups in Korea 
Organisation International Collaborative Effort for DMD
Country Global 
Sector Academic/University 
PI Contribution New collaborations and interactions with groups in Korea working on dementia
Collaborator Contribution New collaborations and interactions with groups in Korea working on dementia
Impact New collaborations and interactions with groups in Korea working on dementia
Start Year 2012
 
Description Single molecule translation imaging in axonal growth cones (Christine Holt) 
Organisation University of Cambridge
Department Department of Pathology
Country United Kingdom 
Sector Academic/University 
PI Contribution We have developed a new technique for single molecule translation imaging in neuronal growth cones.
Collaborator Contribution The biological system was developed in the Holt laboratory. Sample preparation and labelling strategies were developed by Holt et al.
Impact Publications: DOI:10.1016/j.neuron.2015.10.030 Multidisciplinary: Developmental biology, neuroscience, biophysics
Start Year 2015
 
Description Study with international partners 
Organisation International Collaborative Effort for DMD
Country Global 
Sector Academic/University 
PI Contribution We organized and led a new large international study (Canada/Europe/US) that demonstrated that the C9orf72 gene is a common cause of ALS and FTD but not of AD or PD [Xi, et al, 2012 PMID:22964832].
Collaborator Contribution We organized and led a new large international study (Canada/Europe/US) that demonstrated that the C9orf72 gene is a common cause of ALS and FTD but not of AD or PD [Xi, et al, 2012 PMID:22964832].
Impact We organized and led a new large international study (Canada/Europe/US) that demonstrated that the C9orf72 gene is a common cause of ALS and FTD but not of AD or PD [Xi, et al, 2012 PMID:22964832].
Start Year 2012
 
Description University of Cambridge, Department of Zoolology 
Organisation University of Cambridge
Department Department of Zoology
Country United Kingdom 
Sector Academic/University 
PI Contribution Collaboration with Dr. Maria Giannakou
Collaborator Contribution Collaboration with Dr. Maria Giannakou
Impact Collaboration with Dr. Maria Giannakou
Start Year 2012
 
Company Name Cantabio Pharmaceuticals 
Description New company identify novel therapies of Parkinson and Alzheimer Disease 
Year Established 2015 
Impact Just started
Website http://www.cantabio.com/
 
Description 10th UK-Korea Neuroscience Symposium in London (21-22 Aug. 2017) 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact UK-Korea Neuroscientists presented their updated finding and discussed how to translate these for therapeutic applications in the future.
Year(s) Of Engagement Activity 2017
URL https://www.ukorea.ac.uk/10th-uk-korea-neuroscience-symposium-21st-22nd-august-2017-the-royal-societ...
 
Description 15 international conferences in 2016 - speaker 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact conference presentations at internationa; meetings: Black Forest Winter Conference: "Autophagic Membrane Trafficking & Dynamics in Ageing and Disease" (Freiburg 2016), CHDI's 11th Annual Therapeutics Conference (Palm Springs 2016), International Congress of Human Genetics (Kyoto, 2016), Neuroscience School of Advanced Studies - Autophagy and neuroprotection (Cortona - lecture course 2016), International Society for Developmental Neuroscience (2016, Juan les Pins), European Neuroscience Institute 15th Anniversary Symposium (Gottingen 2016), Keystone Autophagy symposium (Whistler, 2016), Mitochondria: balancing health and disease (London 2016), Nobel conference - The Cell Cycle and Cell Death in Disease (Stockholm, 2016), Centre for Translational Cell Research opening sympiosium (Freiburg 2016), PhD graduate Symposium Cologne Graduate School of Aging Research (2016), Cold Spring Harbor meeting: Neurodegenerative Diseases: Biology & Therapeutics (Cold Spring Harbor 2016), Milner Therapeutics Institute Symposium (Cambridge 2016), 26th Annual Meeting of the Network for European CNS Transplantation & Restoration (NECTAR), Cambridge 2016)
Year(s) Of Engagement Activity 2016
 
Description 17th European Congress of Psychiatry, Lisbon 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Discussion afterwards.

N/A
Year(s) Of Engagement Activity 2009
 
Description 26th Neuropharmacology Conference (San Diego) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact This conference discussed about the synaptic mechanisms in various brain diseases. 100 postdoctoral researchers and 100 postgraduate students were attended and more than 100 academic profession including industry.
Year(s) Of Engagement Activity 2016
 
Description 2nd Annual Neuroscience R&D Technologies Conference (London) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact This conference aims at creating a platform for all the stakeholders to discuss, brainstorm and find answers to the ongoing question & challenges in the neuroscience research and recent advancements in neuroscience R & D technologies.
Year(s) Of Engagement Activity 2016
 
Description 3rd Annual Neuroscience R&D Technologies Conference, London (28-29/Sep. 2017) 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact More than 100 academia and industries discussed new technology and finding for Neurodegenerative disease research.
Year(s) Of Engagement Activity 2017
URL http://www.mnmconferences.com/3rd-Annual-Neuroscience-R-D-Technologies-Conference#Speakers
 
Description 7th International Symposium on Geriatrics and Gerontology 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Participants in your research and patient groups
Results and Impact Discussion afterwards

N/A
Year(s) Of Engagement Activity 2011
 
Description Access Employment lecture 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? Yes
Type Of Presentation Keynote/Invited Speaker
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Lecture by Dr. Ekaterina Rogaeva to a general audience regarding her career experience as an immigrant to Canada, and pursuing a career in neuroscience. Organized by charitable organization "Access Employment".
Year(s) Of Engagement Activity 2012
 
Description CONNECTIONS Lecture Series: Ageing Society 
Form Of Engagement Activity Scientific meeting (conference/symposium etc.)
Part Of Official Scheme? Yes
Type Of Presentation Keynote/Invited Speaker
Geographic Reach Local
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact CONNECTIONS brings prominent speakers to Cambridge University to discuss topical issues and forge new ties between people inside and outside academia.

As well as being a lecture series, CONNECTIONS links Cambridge University students with senior members of academia, government and industry. This inter-disciplinary mix of people allows the exchange of ideas and creates unique networking opportunities.
Year(s) Of Engagement Activity 2012
 
Description Dementia Showcase 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach National
Primary Audience Policymakers/politicians
Results and Impact PM Office and department of heath sponsored showcase

Industrial collaboratoins
Year(s) Of Engagement Activity 2012
 
Description Episode of Elemental Ideas on Cambridge TV 25 Minute TV show about super-resolution microscopy 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Clemens Kaminski, Gabriele Kaminski Schierle, Colin Hockings, Florian Ströhl, Nathan Curry

Episode of Elemental Ideas on Cambridge TV 25 Minute TV show about super-resolution microscopy
01/07/2016 Explaining research to the public through a video of our group's lab and research work, with interviews of the two group leaders and several postdoctoral research associates and PhD students.
The videos can be accessed for free online.

Elemental Ideas is Cambridge TV's science magazine programme. They've produced more than 50 programmes since August 2015, covering research topics including string theory, diabetes, exoplanets, vulcanology, epigenetics and the wildlife of New Zealand.
Year(s) Of Engagement Activity 2016
URL http://www.cambridge-tv.co.uk/super-resolution-microscopy/
 
Description Gladstone/DZNE Workshop for Alzheimer's disease, Germany 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Discussion afterwards.

N/A
Year(s) Of Engagement Activity 2012
 
Description Hippocampus Conference in Sicily, Italy (2-6 June 2017) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Research conference at Sicily (June 2017), more than 200 neuroscientists joined and discussed their new findings.
Year(s) Of Engagement Activity 2007
URL http://hippo.euroconferences.org/program.html
 
Description IBRO-APRC Advanced School in Korea (18-27 Oct. 2017) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Postgraduate students
Results and Impact The "IBRO-APRC Advanced School" provided an interactive platform for young aspiring neuroscientists (Ph.D students, post-doctoral fellows, and junior researchers) in the Asia-Pacific region to discuss and promote their understanding of brain functions including cellular mechanisms, synaptic connections, and dynamic patterns of activity.
Year(s) Of Engagement Activity 2017
URL http://www.kbri.re.kr/new/pages/sub/page.html?mc=3352
 
Description Korea-UK Alzheimer's research symposium 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Established UK-Korea Alzheimer's disease research consortium

N/A
Year(s) Of Engagement Activity 2011
 
Description Korea-UK Symposium for Alzheimer's disease research consortium, Seoul 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Discussion afterwards.

N/A
Year(s) Of Engagement Activity 2013
 
Description Korean TV (KBS)-Ageing and Dementia talk 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact TV presentation live programme.

N/A
Year(s) Of Engagement Activity 2014
 
Description Lectures of community leaders at the Dominion Institute 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? Yes
Type Of Presentation Keynote/Invited Speaker
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Lectures of community leaders at the Dominion Institute (Educational program of the Provincial Government of Ontario, Canada; "Passages to Canada").
Year(s) Of Engagement Activity 2012
 
Description Leibniz Institute for Neurobiology Symposium for Neural Plasticity, Germany 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Discussion afterwards

N/A
Year(s) Of Engagement Activity 2012
 
Description Research exchange meeting with DAAD students 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Undergraduate students
Results and Impact Organised a visit (lab tours and research lectures) for German Biophysics students funded under the "Studienstiftung" programme
Year(s) Of Engagement Activity 2016
 
Description Royal Society-Korean Ministry of Science Forum, London 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Policymakers/politicians
Results and Impact Discussion afterwards.

After my talk, established IBS (Korea)- Royal Society (UK) join symposium in Korea
Year(s) Of Engagement Activity 2013
 
Description Showcasing research to public in a hands on manner at the Cambridge Science Festival 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact Cambridge Science Festival
Showcasing research to public in a hands on manner through various experiments organised in the dept of Chemistry including looking at neurons under a microscope.
Explaining the group's research to the public
Undertaken by several members of the group on a yearly basis since 2016

The Science Festival provides the public with opportunities to explore and discuss issues of scientific interest and concern and to raise aspirations by encouraging young people to consider a career in science, technology, engineering or mathematics.

Each year, the Festival welcomes visitors to hundreds of events and receives extensive national and local media coverage. Over 170 event coordinators organise talks, interactive demonstrations, hands-on activities, film showings and debates with the assistance of around 1,000 staff and students from departments and organisations across the University and research institutions, charities and industry in the eastern region. In addition, over 150 people volunteer their time to act as stewards to ensure visitors have a safe and enjoyable Festival experience.
Year(s) Of Engagement Activity 2016,2017
URL http://www.sciencefestival.cam.ac.uk/
 
Description Society for Neuroscience (USA) 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact 250 audience attended for scientific debate, "Synaptic pathophysiology of Alzheimer's disease".
Year(s) Of Engagement Activity 2016
 
Description Spring Hippocampus Conference, Taomina Sicily 2019 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other audiences
Results and Impact More than 300 Scientists joined this conference and discussed new outcome: neuronal circuit and molecular dynamics of hippocampus in physiological and pathological condition.
Year(s) Of Engagement Activity 2019
 
Description Superresolution public video 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Video interview and research video to explain superresolution microscopy in medical research to a lay audience. Currently >14000 views.
Year(s) Of Engagement Activity 2015
URL https://www.youtube.com/watch?v=W-0GWbOFT3w
 
Description Talk and lab tour to funders of ARUK, Feb 2016 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Supporters
Results and Impact Engage with funders on the research carried out thanks to their donations
Year(s) Of Engagement Activity 2016
 
Description Talk and lab tour to funders of ARUK, May 2015 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Supporters
Results and Impact Engage with funders on the research carried out thanks to their donations
Year(s) Of Engagement Activity 2015
 
Description Talk on A short history of Microscopy, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Public lecture on A short history of Microscopy
Year(s) Of Engagement Activity 2017
 
Description The Royal Society London LTP40 meeting, London 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Talk sparked questions

N/A
Year(s) Of Engagement Activity 2013
 
Description Two high school lectures 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach Local
Primary Audience Schools
Results and Impact Two lectures to students at Bishop Strachan high school in Toronto
Year(s) Of Engagement Activity 2012
 
Description UK Age Research Forum (UKARF) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? Yes
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact A lecture series (three lectures) given the Royal College of Physicians to lay and professional caregivers of patients with Alzheimer's.

Increased attention by the lay media, and at least one visit from a sixth form school pupil.
Year(s) Of Engagement Activity 2011
 
Description UK-JAPAN Neuroscience Symposium 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact 80 Neuroscientists and Japanese Medical Research Funding agent (AMED) and MRC attended for UK-JAPAN Symposium for Neurodegenerative disease. Formal research presentation and debate were scheduled over two days programme (5-6/March 2018) at the Royal Society London. AMED expressed their vision and strategy for collaboration with UK funding agent (eg, MRC) and they would like to put new policy and programme.
Year(s) Of Engagement Activity 2008
URL https://www.eventbrite.co.uk/e/uk-japan-neuroscience-symposium-tickets-41205943085
 
Description UK-Korea Spring Health Forum 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Policymakers/politicians
Results and Impact UK-Korea Spring Health Forum was funded by FCO and Korea Ministry of Health and Welfare. This forum aims for developing medical research and healthcare policy relationship in new fields of interest. Panel discussion concluded new policy for ageing and related R&D strategy.
Year(s) Of Engagement Activity 2017
 
Description World Presidents' Organisation educational event 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact 50 Presidents of large UK corporations.

Increased interest in the support for research on Alzheimer's disease.
Year(s) Of Engagement Activity 2011